Creative Biolabs-Immuno-oncology

Anti-CD83 (clone 39QA2E) SynExpress C-Cy5-β-B Modified CD8+ T cells (CAT#: ITS-1224-CR1872)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD83 (clone 39QA2E). We employs the pCDNA (CMV-Cy5-β-catenin-BamHI) vector components and the SynExpress system of the Exons Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD83
Clone
39QA2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
β-catenin
Insertion Sites
BamHI
Gene Modification
Base Editing
Modification Domain
Exons
Carrier Type
pCDNA
Transformation Accuracy
0.94
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.